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Cytopenias are key prognostic indicators of life-
threatening infection, contributing to immunosup-
pression and mortality. Here we define a role for
Caspase-1-dependent death, known as pyroptosis,
in infection-induced cytopenias by studying inflam-
masome activation in hematopoietic progenitor
cells. The NLRP1a inflammasome is expressed in
hematopoietic progenitor cells and its activation trig-
gers their pyroptotic death. Active NLRP1a induced
a lethal systemic inflammatory disease that was
driven by Caspase-1 and IL-1b but was independent
of apoptosis-associated speck-like protein contain-
ing a CARD (ASC) and ameliorated by IL-18. Surpris-
ingly, in the absence of IL-1b-driven inflammation,
active NLRP1a triggered pyroptosis of hematopoi-
etic progenitor cells resulting in leukopenia at
steady state. During periods of hematopoietic
stress induced by chemotherapy or lymphocytic
choriomeningitis virus (LCMV) infection, active
NLRP1a caused prolonged cytopenia, bone marrow
hypoplasia, and immunosuppression. Conversely,
NLRP1-deficient mice showed enhanced recovery
from chemotherapy and LCMV infection, demon-
strating that NLRP1 acts as a cellular sentinel to alert
Caspase-1 to hematopoietic and infectious stress.
INTRODUCTION
The production of IL-1b and IL-18 can be triggered by innate
immune receptors such as NLRP3, which form inflammasome
complexes to activate Caspase-1 after recognition of infection
and host tissue damage (Martinon et al., 2009). However, the
most ancient function for this family of innate immune receptors
canbe tracedback toplantnucleotide-binding leucine-rich repeat
(NB-LRR) proteins, where activating mutations cause cell deathImm(Bernoux et al., 2011; Dietrich et al., 1994; Swiderski et al.,
2009). Activation of mammalian nucleotide-binding oligomeriza-
tion domain, leucine-rich repeat (NLR) proteins can also cause
cell death (Fernandes-Alnemri et al., 2007; Fink et al., 2008), but
the importance ofCaspase-1 activation and pyroptosis in disease
states is unclear. For example, it is known that NLRP3-activating
mutations in humans can be effectively treated by neutralizing IL-
1b, suggesting that cell death induced by NLRP3 activation does
not play a significant role in pathology (Lachmann et al., 2009).
Similarly, the NLRP1b inflammasome is activated by anthrax
lethal toxin to cause macrophage pyroptosis, but this does not
play a role in anthrax sensitivity in vivo (Moayeri et al., 2003; Terra
et al., 2010). Sepsis is commonly associated with a range of cyto-
penias including anemia, lymphopenia, neutropenia, and throm-
bocytopenia, but the etiological triggers for these conditions
havenotbeenelucidated.Herewe report thephysiological conse-
quences of unrestrained NLRP1a activation in the absence of IL-
1b-induced inflammation. We show that this results in pyroptosis
of hematopoietic progenitor cells and compromises hematopoi-
esis during periods of hematopoietic and infectious stress.
NLRP1 expression is highly restricted to the hematopoietic
cell compartment and its expression and function is guided by
several regulatory mechanisms and putative protein interactions
(Kummer et al., 2007). The sterol regulatory element binding
protein-1a (SREBP-1a) basic helix-loop-helix leucine zipper tran-
scription factor differentially regulates the expression of inflam-
mation-related genes including Nlrp1a in hematopoietic cells. It
is hypothesized that Nlrp1a expression is regulated at an addi-
tional level via NF-kB-responsive elements in the Srebp1a
promoter, allowing the induction of Srebp1a and Nlrp1a during
conditions of hematopoietic and infectious stress (Im et al.,
2011). At a posttranslational level, NLRP1 undergoes autocleav-
ageatSer1213 in theFIINDdomain (ZU5-andUPA-likedomains),
which is required for its function (D’Osualdo et al., 2011; Finger
et al., 2012; Levinsohn et al., 2012). NLRP1 function can also by
regulatedbyseveral interactingpartners. Theprosurvival proteins
Bcl-2 and Bcl-xL can bind NLRP1 and inhibit its activation and
oligomerization via interactions between the leucine-rich repeats
(LRR) of NLRP1 and the loop regions of Bcl-2 and Bcl-xL (Bruey
et al., 2007). This NLRP1-inhibitory activity is independent of theunity 37, 1009–1023, December 14, 2012 ª2012 Elsevier Inc. 1009
Figure 1. Inflammatory Disease Induced by
the NLRP1aQ593P Mutation
Hematoxylin and eosin-stained tissues show
pneumonitis (A), meningitis (B), and hepatitis (C) in
Nlrp1aQ593P/Q593P mice. See also Figure S1.
Immunity
NLRP1 Activation Induces Progenitor Cell Deathwell-documented prosurvival functions of Bcl-2 and Bcl-xL and
occurs prior to formation of the inflammasome complex.
To date, no studies have described the specific consequences
of unrestrained pyroptosis in vivo or NLRP1 inflammasome
activation in the absence of infection. Here we show the effect
of an activating mutation in NLRP1 as well as NLRP1 deficiency
in response to hematopoietic stress induced by infection or
chemotherapy. We demonstrate that this inflammasome activity
induces IL-1b-dependent autoinflammation and IL-1b-indepen-
dent deletion of hematopoietic progenitor cells.
RESULTS
Identification of NLRP1a Mutant Mice
Autoinflammatory disease and acute inflammatory diseases
such as sepsis are commonly associated with neutrophilia. To1010 Immunity 37, 1009–1023, December 14, 2012 ª2012 Elsevier Inc.identify genetic regulators of these
conditions, we performed an N-ethyl-N-
nitrosourea (ENU) mutagenesis screen
for dominant mutations that cause
neutrophilia in G1 mice and isolated
a pedigree that was named Neut1 (Fig-
ure S1 available online). The Neut1muta-
tion was genetically mapped via standard
positional cloning techniques to a 700
kbp interval on chromosome 11 between
70.5 and 71.2 Mbp, and sequence anal-
ysis identified a point mutation in the
gene encoding Nlrp1a, predicted to
cause a glutamine-to-proline substitution
at amino acid 593 (Nlrp1aQ593P). This
region of the protein is likely to be a
flexible linker region between the
NACHT (nucleotide-binding, NB) and
LRR domains, where activating muta-
tions are found in other NB-LRR proteins
in plants (Bendahmane et al., 2002;
Moffett et al., 2002; Zhang et al., 2003).
Nlrp1a+/Q593P congenic BALB/c mice
were fertile and remained healthy to at
least 8 months of age, despite histolog-
ical evidence of a multiorgan neutrophilic
inflammatory disease characterized by
meningitis, hepatitis, pneumonitis, pan-
creatitis, pulmonary peri-arteritis, myo-
carditis, and inflammatory bowel disease.
In Nlrp1aQ593P/Q593P homozygotes, a
similar but lethal condition developed by
3–5 months of age (Figure 1). Neutrophil
counts in these animals were 15-fold
higher than in wild-type, and they ex-
hibited lymphopenia and splenomegaly(Figure 2A and Table S1). The peritonitis in Nlrp1aQ593P/Q593P
homozygotes was associated with a loss of peritoneal macro-
phages (Table S1). These data demonstrate that active NLRP1a
drives a systemic inflammatory phenotype that can be distin-
guished from inflammatory disease induced by active NLRP3
(Brydges et al., 2009).
Inflammatory Disease in NLRP1a Mutant Mice Is
Dependent on IL-1b and Caspase-1 but Independent
of ASC and Caspase-11
The semidominant nature of theNlrp1aQ593Pmutation suggested
that the allele produces a constitutively active—or more easily
activated—form of NLRP1a.We therefore conducted an analysis
of inflammasome activity in bonemarrow-derivedmacrophages.
Cells were primed with LPS and stimulated with a range of
inflammasome activators, and supernatants were analyzed for
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Figure 2. Caspase-1 and IL-1b Are Major Contributors to NLRP1aQ593P-Induced Disease
(A) Effects of heterozygous and homozygous Nlrp1aQ593P mutations on peripheral blood neutrophil numbers in mice on a BALB/c background.
(B) Nlrp1aQ593P/Q593P macrophages were treated with 2 ng/ml LPS for 4 hr before the inflammasome was activated with 5 mM ATP for 30 min or MDP complexed
with TiO2, 100 mg/ml uric acid crystals (MSU), 7 mg/ml poly(dA:dT) (dsDNA), or alum for 15 hr. IL-1b secretion was assessed by immunoblot with antibodies
specific for the 35 kDa pro-IL-1b and the processed, bioactive 17 kDa IL-1b.
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NLRP1 Activation Induces Progenitor Cell Deaththe 17 kDa processed form of IL-1b. In contrast to wild-type
macrophages, LPS priming alone was sufficient to induce
Nlrp1aQ593P/Q593P cells to secrete significant amounts of pro-
cessed IL-1b whereas additional activation by ATP, MDP/TiO2,
MSU, or alum were required for IL-1b processing by wild-type
macrophages (Figure 2B). The increased amount of secreted
IL-1b from Nlrp1aQ593P/Q593P cells was not due to alterations in
TLR4-induced activation of NF-kB or MAP kinase activation,
and no changes in the short-term induction of pro-IL-1b was
noted in cell lysates of Nlrp1aQ593P/Q593P macrophages (Fig-
ure S2). Serum IL-1b was below the limit of detection in the
majority of Nlrp1aQ593P/Q593P mice; however, G-CSF and IFN-g
levels were elevated in Nlrp1aQ593P/Q593P mice (Figure 2C). To
determine the contribution cytokines make to Nlrp1aQ593P-
mediated disease, we first generated Nlrp1aQ593P/Q593P mice
lacking either the interleukin-1 receptor (IL-1R) or IL-1a.
Nlrp1aQ593P/Q593PIl1r/ mice did not develop inflammatory
disease (Figure 2D). In contrast, Nlrp1aQ593P/Q593PIl1a/ mice
developed neutrophilia and a lethal systemic inflammatory
disease (Figures 2E and 2F), indicating that the phenotype of
Nlrp1aQ593P/Q593P mice is largely attributable to the activity of
IL-1b. Nlrp1aQ593P/Q593PCasp1/ mice did not develop neutro-
philia or inflammatory disease and exhibited survival rates equiv-
alent to wild-type counterparts (Figures 2G and 2H).
The NLRP3 and AIM2 inflammasome require the recruitment
of the adaptor protein apoptosis-associated speck-like protein
containing a CARD (ASC) through a pyrin-pyrin domain interac-
tion. The lack of a pyrin domain in mouse NLRP1a suggested
that ASC was unlikely to interact or influence the phenotype of
Nlrp1aQ593P/Q593P animals. As predicted, Nlrp1aQ593P/Q593P
Asc/ mice developed neutrophilia and lethal inflammatory
disease at the same rate as Nlrp1aQ593P/Q593P littermate controls
(Figures 2I and 2J), indicating that ASC is not required for
NLRP1a-mediated responses in mice, distinguishing this from
NLRP3- and AIM2-dependent models of inflammation.
It has been documented that the conventionally derived
Caspase-1-deficient mice used in these experiments are
also genetically deficient in Caspase-11, a putative interacting
partner for NLRP1 (Kayagaki et al., 2011; Martinon et al.,
2002). To confirm that the inflammatory phenotype was a conse-
quence of Caspase-1 activation and not Caspase-11 activation,
we generated Nlrp1aQ593P/Q593PCasp11/ mice. Deficiency of
Caspase-11 did not prevent neutrophilia, lymphopenia,monocy-
topenia, or the systemic inflammatory disease (Figure 2K and
data not shown), indicating that NLRP1a predominately acti-
vates Caspase-1.
IL-18 Negatively Regulates NLRP1a-Induced
Inflammation
IL-18 was elevated 20-fold in the serum of Nlrp1aQ593P/Q593P
mice compared to littermate controls (Figure 3A). This was(C) Cytokine levels were measured in the serum of wild-type and Nlrp1aQ593P/Q59
(D) Disease-free survival in Nlrp1aQ593P/Q593P mice deficient in the IL-1R.
(E–J) Neutrophil numbers and disease-free survival in Nlrp1aQ593P/Q593P mice defi
were analyzed at 7 weeks age. A significant change (p < 0.05) in disease-free surv
well as between Nlrp1aQ593P/Q593PCasp1/ and Nlrp1aQ593P/Q593P mice.
(K) Enumeration of neutrophils, lymphocytes, monocytes, and eosinophils in Cas
*p < 0.05. See also Figure S2.
1012 Immunity 37, 1009–1023, December 14, 2012 ª2012 Elsevier InCaspase-1 dependent and only modestly affected by loss
of the IL-1 receptor (Figures 3A and 3B). Furthermore,
Nlrp1aQ593P/Q593P macrophages produced high levels of IL-18
upon stimulation with LPS alone (Figure 3C). By reconstituting
lethally irradiated wild-type mice with Nlrp1aQ593P/Q593P bone
marrow cells, we could show that the elevation in serum IL-18
in Nlrp1aQ593P/Q593P mice was due to defects in hemato-
poietic cells (Figure 3D). To examine the contribution of
IL-18 to NLRP1aQ593P-mediated disease, we generated
Nlrp1aQ593P/Q593PIl18/ mice. Remarkably, deletion of IL-18
increased the number of neutrophils in the blood (Figure 3E)
and greatly accelerated the onset of disease (Figure 3F).
Nlrp1aQ593P/Q593PIl18/ mice succumbed to disease at
5–10 weeks of age in contrast to Nlrp1aQ593P/Q593P littermate
controls, in which disease was apparent only at 3–5 months of
age (Figure 3F). This could not be attributed to IL-18 negatively
regulating IL-1b production, because IL-18 pretreatment of
dendritic cells or macrophages did not inhibit IL-1b production
(Figure S3). Histological analysis revealed striking differences
from littermate Nlrp1aQ593P/Q593P controls (Table 1). Myocarditis
was more frequent and probably contributed to the rapid
deterioration of these animals (Figure 3F and Table 1). This is
consistent with a proposed role for IL-18 in the prevention of
myocardial necrosis and inflammatory cell infiltration during
infection (Yoshida et al., 2002). Neutrophilic infiltration was not
observed in the livers of Nlrp1aQ593P/Q593PIl18/mice, suggest-
ing a potential proinflammatory role for IL-18 in this organ
(Table 1).
IL-18 Does Not Negatively Regulate NLRP1a-Induced
Inflammatory Disease via IFN-g
IL-18 was originally identified as a cytokine that could potently
induce IFN-g in synergy with IL-12 (Okamura et al., 1995). We
and others have shown previously that IFN-g can negatively
regulate IL-1b production (Masters et al., 2010). We therefore
hypothesized that IL-18 was regulating infection-induced
systemic inflammation in NLRP1a mutant mice via IFN-g.
Nlrp1aQ593P/Q593PIfng/ mice uniquely developed encephalitis,
demonstrating a tissue-specific role for IFN-g in the negative
regulation ofNLRP1a-induced inflammation in thebrain (Table 1).
However, Nlrp1aQ593P/Q593PIfng/ mice did not phenocopy
Nlrp1aQ593P/Q593PIl18/ mice. Blood neutrophil numbers and
survival curves inNlrp1aQ593P/Q593PIfng+/+ andNlrp1aQ593P/Q593P
Ifng/ animals were indistinguishable (Figures 3G and 3H).
Thus, IL-18 negatively regulates Nlrp1aQ593P/Q593P-induced
systemic inflammation independently of IFN-g.
T Cells Negatively Regulate Cutaneous Inflammatory
Disease in NLRP1a Mutant Mice
Guarda et al. (2009) recently proposed a key role for T cells in
the negative regulation of the NLRP1 inflammasome. We tested3P mice. *p < 0.05, mean ± SD, n = 3 independent samples.
cient in IL-1a, Caspase-1, or ASC. Neutrophil numbers in the peripheral blood
ival is evident between Nlrp1aQ593P/Q593PIl1a/ and Nlrp1aQ593P/Q593P mice, as
p11/Nlrp1aQ593P/Q593P mice.
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Figure 3. IL-18 Inhibits the Lethal Multiorgan Inflammatory Disease in Nlrp1aQ593P/Q593P Mice
(A and B) Serum IL-18 was measured by ELISA in wild-type,Casp1/, Nlrp1aQ593P/Q593P,Nlrp1aQ593P/Q593PCasp1/, Il1r/, and Nlrp1aQ593P/Q593PIl1r/mice.
(C) IL-18 production by Nlrp1aQ593P/Q593P macrophages after stimulation with 2 ng/ml LPS and 5 mM ATP.
Immunity
NLRP1 Activation Induces Progenitor Cell Death
Immunity 37, 1009–1023, December 14, 2012 ª2012 Elsevier Inc. 1013
Table 1. Regulators of Pathology in Nlrp1aQ593P/Q593P Mice
Tissue Abnormality WT
Nlrp1aQ593P/Q593P
Il1r/ Il18/ Ifng/ Casp1/ Cd3/
Liver neutrophil foci 0/8* 4/7 0/6 0/9* 7/9 0/13* 7/7
Lung neutrophil infiltration 0/8* 6/7 0/6* 9/9 9/9a 0/13*,b 6/7
Spleen depleted follicles 0/8* 6/7 0/6* 9/9 9/9 0/8* 8/8
excess granulocytes 0/8* 7/7 0/6* 9/9 9/9 0/8* 8/8
Bone marrow excess granulocytes 0/8* 7/7 1/5* 9/9 7/7 0/9* 2/2
Brain neutrophils in meninges 0/8* 5/6 0/3* 8/8 9/9c 0/13* 5/7d
Gut neutrophil invasion or
granuloma
0/9* 6/7 0/5* 8/9 6/9 1/13* 6/8
Heart neutrophil infiltration 0/8 1/4 0/6 9/9* 5/9 0/13 5/7
Skin ulceration 0/8 0/7 0/6 0/9 0/9 0/13 6/7*
a4/9 lungs with lymphoid foci.
b2/13 lungs with lymphoid infiltrates.
c6/9 encephalitis.
d3/7 with neutrophil foci in brain.
*p < 0.05, Nlrp1aQ593P/Q593P versus other genotypes.
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and pathology in T cell-deficient Nlrp1aQ593P/Q593PCd3/ mice.
No change in neutrophilia was evident (Figure 3I), but a
modest reduction in disease-free survival was observed in
Nlrp1aQ593P/Q593PCd3/ mice relative to Nlrp1aQ593P/Q593P
littermate controls (Figure 3J) resulting from a severe cutaneous
inflammatory disease characterized by neutrophil infiltration
of the dermis (Table 1). This disease was not seen in
Nlrp1aQ593P/Q593PIl18/, Nlrp1aQ593P/Q593PIfng/, or B cell-
deficient Nlrp1aQ593P/Q593PmMT/ mice (Figures 3K and 3L
and Table 1). These data confirm a highly specific role for
T cells in the negative regulation of NLRP1a-mediated inflamma-
tion in the skin, which could be due to the absence of regulatory
T cells or the absence of CD40-induced regulation of the inflam-
masome, as proposed by Guarda et al. (2009). However, the
actions of neither IFN-g nor T cells can explain the inhibitory
effect of IL-18 on NLRP1aQ593P-mediated inflammatory disease.
Microbes Contribute to Systemic Inflammatory Disease
in the Absence of IL-18
To investigate the role of commensal organisms in the
acute inflammatory disease in Nlrp1aQ593P/Q593PIl18/ and
Nlrp1aQ593P/Q593P mice, we rederived Nlrp1aQ593P/Q593PIl18/
mice and littermate controls to a germ-free environment.
Germ-free Nlrp1aQ593P/Q593P mice exhibited neutrophilia and
myocarditis (Figures 3M and S3), indicating that microbes are
not required to initiate disease. However, germ-free
Nlrp1aQ593P/Q593PIl18/ mice were indistinguishable from litter-
mate germ-freeNlrp1aQ593P/Q593P mice, such that at 10 weeks of
age when 75% of conventionally housed Nlrp1aQ593P/Q593P
Il18/ mice succumb to disease, no mortality was observed in(D) Serum IL-18 levels in lethally irradiated mice after reconstitution with Nlrp1aQ
(E–L) Neutrophil numbers in the peripheral blood of Nlrp1aQ593P/Q593P mice lacking
lacking IL-18 (F), IFN-g (H), T cells (J), or B cells (L). A significant change (p < 0
Nlrp1aQ593P/Q593P mice, as well as between Nlrp1aQ593P/Q593PCd3/ and Nlrp1a
(M) Neutrophil numbers in the peripheral blood of germ-free Nlrp1aQ593P/Q593PIl1
*p < 0.05. See also Figure S3.
1014 Immunity 37, 1009–1023, December 14, 2012 ª2012 Elsevier Ingerm-free Nlrp1aQ593P/Q593PIl18/ mice. Moreover, no signifi-
cant differences in neutrophil numbers were observed between
Nlrp1aQ593P/Q593PIl18/andNlrp1aQ593P/Q593Pmice (Figure 3M).
These data indicate that microbes accelerate the onset and the
severity of the disease of Nlrp1aQ593P/Q593P mice.
NLRP1a Activation Induces Deletion of Hematopoietic
Progenitor Cells
To examine the role of hematopoietic cells in
Nlrp1aQ593P-driven disease, we transplanted wild-type or
Nlrp1aQ593P/Q593P bone marrow into lethally irradiated wild-
type or Nlrp1aQ593P/Q593P recipient mice. Nlrp1aQ593P/Q593P
bone marrow induced neutrophilia, lymphopenia, and inflam-
matory disease in wild-type recipients, demonstrating that the
phenotype is intrinsic to hematopoietic cells (Figure 4A and
data not shown). In the reciprocal experiment, neutrophilia
and inflammatory disease in Nlrp1aQ593P/Q593P animals was
ameliorated by transplantation of wild-type bone marrow. In
some recipients of Nlrp1aQ593P/Q593P bone marrow, we
observed a decrease in engraftment that correlated with
a reduction in the severity of multiorgan inflammatory disease
in the host (Figures 4B and 4C). This variable reconstitution effi-
ciency raised the possibility that the Nlrp1aQ593P mutation
might affect the function of hematopoietic stem and/or progen-
itor cells. Consistent with this, we found that NLRP1a was
highly expressed in hematopoietic stem cells and progenitor
cells of both myeloid and lymphoid origin (Figure 4D), and
Nlrp1aQ593P/Q593P mice exhibited a reduction in the proportion
of lineagec-kit+ cells in the bone marrow that was dependent
on Caspase-1 but independent of the IL-1 receptor (Figure 4E).
We therefore performed competitive bone marrow transplants,593P/Q593P or wild-type bone marrow cells.
IL-18 (E), IFN-g (G), T cells (I), or B cells (K). Survival of Nlrp1aQ593P/Q593P mice
.05) in disease-free survival is evident between Nlrp1aQ593P/Q593PIl18/ and
Q593P/Q593P mice.
8/ and Nlrp1aQ593P/Q593P mice.
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Figure 4. NLRP1a Activation Influences Myelopoiesis
(A) Transfer of Nlrp1aQ593P/Q593P bone marrow to lethally irradiated wild-type recipients results in neutrophilia and B and T lymphopenia. The transfer of wild-type
bone marrow to lethally irradiated Nlrp1aQ593P/Q593P mice is sufficient to restore normal hematopoiesis.
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Table 2. The NLRP1aQ593P Mutation Reduces the Frequency of Myeloid Progenitor Cells in the Bone Marrow Independently
of the IL-1R
Genotype Stimulus
Number of Colonies
Blast Neutrophil Granulocyte/Macrophage Macrophage Eosinophil Megakaryocyte
Il1r/ GM-CSF 24 ± 8 7 ± 2 33 ± 17 5 ± 5
G-CSF 15 ± 8 0 ± 0 0 ± 0
M-CSF 2 ± 2 6 ± 6 47 ± 18
IL-3 4 ± 2 27 ± 9 11 ± 6 23 ± 14 3 ± 3 7 ± 8
SCF+IL-6 8 ± 3 24 ± 5 5 ± 3 3 ± 1 1 ± 1 2 ± 2
saline 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0
Il1r/Nlrp1aQ593P/Q593P GM-CSF 13 ± 10 3 ± 2* 8 ± 7* 1 ± 0
G-CSF 7 ± 2* 0 ± 0 0 ± 0
M-CSF 0 ± 0* 0 ± 1 8 ± 4*
IL-3 2 ± 2 9 ± 8* 3 ± 2* 4 ± 2* 1 ± 1 4 ± 3
SCF+IL-6 3 ± 1* 10 ± 8* 1 ± 1* 2 ± 1* 0 ± 0 2 ± 1
saline 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0
*p < 0.05, mean ± SD, n = 4–7 independent experiments. 2.53 104 bonemarrow cells were cultured in the presence of 100 ng/ml murine SCF, 10 ng/ml
rm IL-3, 10 ng/ml rm GM-CSF, 10 ng/ml rm M-CSF or rh G-CSF in 0.3% agar/DME/FCS. After 7 days, cultures were fixed, stained, and counted.
Immunity
NLRP1 Activation Induces Progenitor Cell Deathinjecting equal numbers of wild-type and Nlrp1aQ593P/Q593P
bone marrow cells into lethally irradiated wild-type recipient
mice. Analysis at 8 weeks posttransplant demonstrated that
Nlrp1aQ593P/Q593P hematopoietic stem and progenitor cells
failed to compete with wild-type counterparts, indicating
a cell-intrinsic defect (Figure 4F).
In the absence of the IL-1R (i.e., in Nlrp1aQ593P/Q593PIl1r/
mice), IL-1b-driven inflammatory disease does not develop and
emergency granulopoiesis is not engaged. We were therefore
able to examine the frequency and differentiation of myeloid
progenitor cells without the confounding effects of inflammatory
disease in Nlrp1aQ593P/Q593P mice. We cultured bone marrow
and spleen cells from healthy Nlrp1aQ593P/Q593PIl1r/ mice in
semisolid agar. Table 2 demonstrates significant deficiencies
in macrophage and neutrophil progenitor cells in bone marrow
from Nlrp1aQ593P/Q593PIl1r/ mice. To examine more primitive
lineage-committed myeloid progenitor cells, we cultured bone
marrow in semisolid agar containing SCF+IL-6 for 7 days, picked
individual multipotent blast colonies, and recultured them in
GM-CSF, M-CSF, or SCF+IL-3+Epo for another 7 days.
Analysis of progenitor cells in Nlrp1aQ593P/Q593PIl1r/ blast(B and C) Reduced reconstitution efficiency of Nlrp1aQ593P/Q593P bone marrow in
posttransplant. *p < 0.05 by ANOVA and SNK.
(D) Expression of Nlrp1a, Nlrp3, Asc, and Actin in purified populations of hemato
(CMP), granulocyte-macrophage progenitors (GMP), and common lymphoid pro
(E) Decrease of linc-kit+ hematopoietic progenitor cells in the bone marrow of N
(F) Contribution of wild-type and Nlrp1aQ593P/Q593P bone marrow to lethally irra
Nlrp1aQ593P/Q593P bone marrow cells were initially transplanted.
(G and H) The differentiation of progenitor cells in blast colonies is altered by the
IL-1b. Individual blast colonies fromwhole bonemarrow cultures stimulated with S
in the presence of M-CSF, GM-CSF, or SCF+IL-3+Epo before colony types were
(G) *p < 0.05, mean ± SEM, Il1r/Nlrp1aQ593P/Q593P versus Il1r/, n = 14–16 ind
(H) *p < 0.05, mean ± SEM, n = 19–20 independent recloned colonies from two i
(I) Enumeration of lymphocytes, neutrophils, platelets, monocytes, eosinophils, a
(J) Caspase-1 activity in linc-kit+ bone marrow progenitor cells via FAM-YVAD-
(K) IL-1R-independent but Caspase-1-dependent reduction in viability of Nlrp1aQ
See also Figure S4.
1016 Immunity 37, 1009–1023, December 14, 2012 ª2012 Elsevier Incolonies revealed a deficit in macrophage progenitor cells and
granulocyte-macrophage progenitor cells (Figure 4G). In
Nlrp1aQ593P/Q593P blast colonies but not Nlrp1aQ593P/Q593P
Casp1/ blast colonies, there was a significant decrease in
macrophage progenitor cells (Figure 4H), confirming that the
loss of progenitor cells was a consequence of Caspase-1
activity. These findings indicate that Caspase-1 activation in
myeloid progenitor cells can affect their differentiation to mature
myeloid cells. Reductions in hematopoietic progenitor cell
populations were reflected by significant deficiencies in lympho-
cytes, monocytes, eosinophils, and platelets at steady state in
healthyNlrp1aQ593P/Q593PIl1r/ animals (Figure 4I) and occurred
independently of ASC (Figure S4).
The cell-intrinsic deficiency of progenitor cells in
Nlrp1aQ593P/Q593P mice, which was rescued by deleting
Caspase-1, strongly suggested that these cells were undergoing
pyroptotic cell death. In agreement with this, we could detect
increased Caspase-1 activity in hematopoietic progenitor
populations (Figure 4J). Moreover, there was an increased rate
of death of purified Nlrp1aQ593P/Q593PIl1r/ hematopoietic
progenitor cells cultured ex vivo (Figure 4K) that was not(B) the bone marrow and (C) peripheral blood of irradiated recipients 8 weeks
poietic stem cells (HSC), linc-kit+Sca1+ (LSK), common myeloid progenitors
genitors (CLP).
lrp1aQ593P/Q593P and Il1r/Nlrp1aQ593P/Q593P mice.
diated recipients, 8 weeks posttransplant. Equal numbers of wild-type and
Nlrp1aQ593P mutation through Caspase-1 activity and occurs independently of
CF+IL-6 for 7 dayswere resuspended in agar and incubated for a further 7 days
enumerated. G, granulocyte; GM, granulocyte-macrophage; M, macrophage.
ependent recloned colonies from two independent experiments.
ndependent experiments.
nd red blood cells in Il1r/Nlrp1aQ593P/Q593P mice. *p < 0.05.
FMK Caspase-1 substrate. MFI, mean fluorescence intensity.
593P/Q593P linc-kit+ hematopoietic progenitor cells.
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Figure 5. NLRP1a Activation Prevents Recovery from Hematopoietic Stress
(A) Leukopenia induced by 150 mg/kg 5-fluorouracil in Il1r/Nlrp1aQ593P/Q593P mice at day 12 but not Il1r/ littermate controls. *p < 0.05, mean ± SEM,
n = 3–4 mice.
(B) Reticulocyte numbers 12 days after challenge with 5-fluorouracil. *p < 0.05, mean ± SEM, n = 4 mice.
(C) Hematoxylin and eosin staining of bone marrow of Il1r/Nlrp1aQ593P/Q593P and Il1r/ mice 12 days after treatment with 5-FU.
(D) The composition of blood after injection with 150 mg/kg 5-fluorouracil. *p < 0.05, mean ± SEM, n = 8–18 mice.
(E) Reticulocyte numbers 12 days after challenge with 5-fluorouracil. *p < 0.05, mean ± SEM, n = 8–18 mice.
(F) Spleen weight at steady state or 12 days postinjection with 5-FU. *p < 0.05, mean ± SEM, n = 3–18 mice.
See also Figure S5.
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NLRP1 Activation Induces Progenitor Cell Deathobserved for Nlrp1aQ593P/Q593PCasp1/ progenitor cells (Fig-
ure 4K). In Nlrp1aQ593P/Q593P animals but not Nlrp1aQ593P/Q593P
Il1r/ animals, an increase in granulocyte precursors was
detected when bone marrow was cultured in semisolid agar
for 7 days in hematopoietic growth factors (Table S2). The
IL-1b-dependent emergency granulopoiesis observed in
Nlrp1aQ593P/Q593P mice drives granulocyte expansion but
not lymphocyte or monocyte expansion. In these animals, theImmoverwhelming granulopoietic stimulus driven by IL-1b and
G-CSF (Figure 2C) probably outweighs the pyroptotic death
of granulocyte progenitors caused by active NLRP1a. The
result of NLRP1a activation is a net increase in mature neutro-
phils in the peripheral circulation; however, deleting the IL-1
receptor removes the stimulus for emergency granulopoiesis,
highlighting the pyroptotic defect in hematopoietic stem and
progenitor cells.unity 37, 1009–1023, December 14, 2012 ª2012 Elsevier Inc. 1017
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Figure 6. LCMV Infection Induces Prolonged Cytopenia in NLRP1a Mutant Mice
(A) Enumeration and analysis of red blood cells (RBC), reticulocytes, platelets (PLT), neutrophils, lymphocytes, and monocytes in the blood of mice infected with
LCMV docile. *p < 0.05, mean ± SEM, n = 4–15.
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Immunity
NLRP1 Activation Induces Progenitor Cell DeathEmergency Hematopoiesis Induced by Chemotherapy
Is Compromised by Inflammasome Activation in
Progenitor Cells
To evaluate the effect of active NLRP1a during hematopoietic
stress, Nlrp1aQ593P/Q593PIl1r/ mice (which do not develop
autoinflammatory disease) were challenged with 5-fluorouracil.
Strikingly, thesemice succumbed shortly after the nadir of leuko-
penia at 12 days postinjection. They exhibited hypoplastic bone
marrow, lymphopenia, monocytopenia, and a deficit of reticulo-
cytes, supporting a functional deficiency in hematopoietic
progenitor cells (Figure 5). No significant changes were detected
in the number of bone marrow cells at steady state (Il1r/, 38 ±
13 106 cells versusNlrp1aQ593P/Q593PIl1r/, 30 ± 123 106 cells,
per 2 femurs, n = 3, mean ± SD, p > 0.05). To confirm the phys-
iological relevance of data obtained from mice with active
NLRP1a (Nlrp1aQ593P/Q593P), we generated mice homozygous
for a targeted deletion of the entire Nlrp1 locus (Nlrp1a, Nlrp1b,
and Nlrp1c; Figure S5). NLRP1 deficiency improved recovery
of the hematopoietic compartment after hemoablative chemo-
therapy, with modest increases in the numbers of platelets,
lymphocytes, monocytes, reticulocytes, and spleen weights
compared to littermate controls (Figures 5D–5F).
NLRP1a Activation Prolongs Cytopenia after LCMV
Infection
To further examine the physiological consequences of NLRP1a
activation in hematopoietic progenitor cells, and to investigate
the relationship between inflammasome activation and cytope-
nia during infection, we utilized lymphocytic choriomeningitis
virus (LCMV). LCMV infects bone marrow cells, reduces the
frequency of hematopoietic progenitor cells by 50%–90%, and
induces pan-cytopenia (Binder et al., 1997). We hypothesized
that deficiencies in hematopoietic progenitor cells, specifically
megakaryocyte and erythroid progenitor cells, caused by
NLRP1a activation would exacerbate these effects. Indeed,
infection with LCMV caused thrombocytopenia and severe
bone marrow and splenic hypoplasia in Nlrp1aQ593P/Q593PIl1r/
mice requiring euthanasia (Figures 6A–6D and 6G). Despite func-
tional defects in the hematopoietic system, no changes in viral
titer were observed in Nlrp1aQ593P/Q593PIl1r/ mice compared
to Il1r/ mice (Figure 6E). Tetramer-positive, LCMV-reactive
CD8+ T cells failed to develop inNlrp1aQ593P/Q593PIl1r/ animals
(Figure 6F), suggesting that NLRP1a activation may also impair
adaptive immune responses. To test the ability of LCMV to
directly infect hematopoietic progenitor cells in the bonemarrow,
we purified linc-kit+ bone marrow progenitor cells and infected
them ex vivo with LCMV (Figure 6H). Aswe predicted, LCMVwas
able to directly infect linc-kit+ bone marrow progenitor cells as
assessed by intracellular flow cytometry for LCMV nucleoprotein
and a viral plaque assay (Figure 6H and data not shown). LCMV(B) Nucleated bone marrow and spleen cells 16 days after infection. *p < 0.05, m
(C) Spleen weight of infected mice 16 days after infection. *p < 0.05, mean ± SE
(D) Disease-free survival of Il1r/Nlrp1aQ593P/Q593P mice and littermate controls
(E) Viral titers in the lung, kidney, brain, and spleen calculated by plaque assay.
(F) Tetramer-positive, CD8+ T cells 16 days after infection. *p < 0.05, mean ± SE
(G) Hematoxylin and eosin staining of bone marrow from mice 8 days after infec
(H) Infection of purified linc-kit+ hematopoietic progenitor cells cultured in SCF+
virus was detected by intracellular staining for LCMV nucleoprotein. Representa
Imminfection of progenitor cells increased their rate of cell death, as
assessed by viability staining prior to fixation and permeabiliza-
tion for intracellular staining of LCMV nucleoprotein (Figure 6H).
This cell death was increased in Nlrp1aQ593P/Q593P cells and
was dependent on Caspase-1 (Figure 6H). Taken together, these
data demonstrate that systemic activation of NLRP1a can lead
to a functional defect in hematopoietic progenitor cells and
compromise hematopoiesis, generating severe cytopenia that
contributes to immunosuppression.
To confirm the relevance of data from LCMV-infected
Nlrp1aQ593P/Q593PIl1r/ animals, we examined the response of
NLRP1-deficient mice to LCMV. NLRP1 deficiency impaired
the induction of pan-cytopenia by two different strains of
LCMV and improved recovery from infection (Figures 7
and S6). NLRP1-deficient animals displayed increases in
reticulocytes, platelet numbers, and hematocrit in the peripheral
blood, as well as increases in body weight, spleen weight,
bone marrow B cell precursors, and myeloid, erythroid, and
lymphoid cells in the spleen relative to littermate controls
(Figures 7A–7D). In contrast to Nlrp1aQ593P/Q593PIl1r/ animals,
which display major deficiencies in hematopoietic stem and
progenitor cells, Nlrp1/ animals displayed increases in this
population in the spleen after LCMV infection (Figure 7D).
Moreover, the numbers of splenic tetramer-positive, LCMV-
reactive CD8+ T cells were elevated in Nlrp1/ animals (Fig-
ure 7E). To confirm a cell-intrinsic role for NLRP1 in T cells, we
generated bone marrow chimeras containing equal numbers of
wild-type and Nlrp1/ bone marrow cells. Infection of these
animals demonstrated enhanced development of Nlrp1/,
tetramer-positive, LCMV-reactive CD8+ T cells (Figure 7F),
showing that this effect on the adaptive immune response is
cell intrinsic.
DISCUSSION
This study demonstrates that NLRP1a can generate a functional
Caspase-1-containing inflammasome in vivo, independently of
ASC andCaspase-11, to drive an IL-1b-dependent inflammatory
disease that is negatively regulated by IL-18. Most importantly,
our research indicates cell-intrinsic roles for NLRP1a-induced
pyroptosis in hematopoietic progenitor cells that prevents their
proliferation and differentiation to mature cells. Unrestrained
pyroptosis in hematopoietic stem and progenitor cells leads to
leukopenia at steady state and to anemia and leukopenia during
periods of hematopoietic stress induced by chemotherapy or
infection.
Pyroptosis is reported to be an effective mechanism of
clearance for intracellular bacteria. Here, we propose that the
activity of the NLRP1a complex in hematopoietic progenitor cells
may restrict their proliferation or enable the self-destruction ofean ± SEM, n = 4–8.
M, n = 4–8.
injected with 2 3 106 PFU LCMV. *p < 0.05, n = 5–17.
M, n = 4–8.
tion with LCMV.
IL-3+Epo for 3 days. Viability was assessed with LIVE/DEAD yellow stain and
tive data from triplicate wells of five independent experiments.
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Figure 7. NLRP1 Deficiency Enhances Hematopoietic Responses to LCMV
(A) Peripheral blood parameters of LCMV-infected mice at steady state (day 0) and days 4 and 11 postinfection with LCMV (clone 13). *p < 0.05, mean ± SEM,
n = 4–7.
(B) Weight of mice after infection with LCMV. *p < 0.05, mean ± SEM, n = 6.
(C) Spleen weight 12 days after LCMV infection. *p < 0.05, mean ± SEM, n = 6.
(D) Total nucleated cells in the bone marrow and spleen 12 days after LCMV infection. *p < 0.05, mean ± SEM, n = 6.
(E) Tetramer-positive (LCMV-specific) CD8+ T cells in the spleen 12 days after LCMV infection. *p < 0.05, mean ± SEM, n = 6.
(F) Tetramer-positive (LCMV-specific) CD8+ T cells in the spleen of bone marrow chimeras 12 days after LCMV infection. Chimeric mice were generated by
transplanting lethally irradiated wild-type recipients with equal numbers of wild-type and Nlrp1/ bone marrow cells. *p < 0.05, mean ± SEM, n = 4.
See also Figure S6.
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Immunity
NLRP1 Activation Induces Progenitor Cell Deathinfected cells to limit dissemination of infection during their prolif-
eration and differentiation to mature cells. Profound cytopenias
accompanied by febrile neutropenia (or more commonly neutro-
philia) are commonly found in patients immediately after their
diagnosis with sepsis (Venet et al., 2010). Our data raise the
possibility that anemia, leukopenia, and immunosuppres-
sion during viral infection or sepsis may be a result of inflamma-
some activity in hematopoietic progenitor cells. Transplantation
of lethally irradiated recipients with HSC and additional lineage-
restricted progenitor cells protects against lethal challenge with
mousecytomegalovirus,Aspergillus fumigatus, orPseudomonas
aeruginosa (Arber et al., 2003; BitMansour et al., 2002).
P. aeruginosa-induced lethal sepsis was attributed to a restric-
tion of differentiation from HSCs to lineage-restricted
myeloid progenitor cells because of defects in cell cycle
regulators and transcription factors controlling myeloid cell
differentiation including PU.1, C/EBPa, SKP2, p21cip1, and
LRG47 (Rodriguez et al., 2009). Although no single mechanism
is likely to account for the spectrum of defects observed in sepsis
(a heterogenous disease contributed to by a range of genetic
factors, pathogen virulence factors, and comorbidities), the
contribution of the hematopoietic progenitor cell compartment
is likely to be critical for disease outcome. We propose that
NLRP1a inflammasome activation in hematopoietic progenitor
cells can contribute to cytopenias and adversely affect the out-
come of severe infection or hematopoietic stress induced by
chemotherapy.
Our findings suggest that NLRP1a acts as a cellular sentinel,
poised for activation beyond an evolutionarily determined
threshold. Based on studies of similar proteins in plants, this
threshold is probably set, at least in part, by interactions between
the LRRs and the NACHT domain (Bernoux et al., 2011; Dietrich
et al., 1994; Swiderski et al., 2009). We hypothesize that the
Q593P mutation in the linker region between the LRRs and the
NACHT domains of NLRP1a destabilizes the interaction
between these two domains, reducing the threshold for activa-
tion of NLRP1a. We propose that this leads to an inflammasome
that is more easily activated, thereby inducing the death of
progenitor cells. This compromises hematopoiesis at the steady
state, generating a comorbidity in NLRP1a mutant mice that
severely compromises subsequent responses to hematopoietic
stress induced by chemotherapy or infection. Our data in
NLRP1-deficient mice are consistent with this mode of action
of NLRP1. Eliminating this cellular sentinel does not appear to
compromise hematopoiesis at steady state, but after chemo-
therapy or infection, NLRP1-deficient mice have increased
numbers of hematopoietic progenitor cells and a reduced period
of cytopenia, and they recovermore rapidly than control animals.
In these scenarios, the removal of NLRP1 effectively increases
the resistance of progenitor cells to hematopoietic stress. Future
studies will be required to examine the role of NLRP1 regulators
and NLRP1 function in other settings, where activation of NLRP1
may be essential for responses to infection and cellular stress.
One context where NLRP1 is thought to be important is autoim-
munity, with known human genetic associations to vitiligo, lupus,
rheumatoid arthritis, and celiac disease (Jin et al., 2007; Magitta
et al., 2009; Pontillo et al., 2010, 2012). Activated NLRP1 could
provide an inflammatory stimulus in these diseases; however,
our observation that impaired NLRP1 activation enhancesImmantigen-specific T cell responses shows that T cell-mediated
autoimmunity in humans could be promoted by a lack of
NLRP1 function.
Our data also reveal a crucial role for IL-18 in responding to
infection during inflammatory responses initiated by the NLRP1a
inflammasome. When microbes are present, the loss of IL-18
greatly exacerbates lethal systemic inflammatory disease in
NLRP1a mutant mice. IL-18 has a broad range of pro- and
anti-inflammatory activities, driving the production of IFN-g,
IL-13, IL-4, GM-CSF, IL-1b, IL-8, and TNF-a (Arend et al.,
2008). Targeting IL-18 reduces disease severity in collagen-
induced arthritis (Plater-Zyberk et al., 2001), contact hypersensi-
tivity reactions (Wang et al., 2002), and atherosclerotic lesion
development (Mallat et al., 2001) but increases severity of
DSS-induced colitis and enhances azoxymethane/DSS-induced
adenocarcinoma formation (Salcedo et al., 2010; Zaki et al.,
2010). IL-18 binding protein and a humanized IL-18 monoclonal
antibody are in clinical trials for the treatment of rheumatoid
arthritis, psoriasis, and inflammatory bowel disease (Tak et al.,
2006). Our data highlight unexpected risks that may be associ-
ated with neutralizing IL-18 and suggest that these therapeutics
should be used with caution when the mechanism of inflamma-
tory disease is not well understood.
Our data on mutant NLRP1a are consistent with activating
mutations in the same region of more ancient NB-LRR proteins
in plants that also cause cell death (Bernoux et al., 2011; Dietrich
et al., 1994; Swiderski et al., 2009). This conserved mechanism
and function indicate a central role for pyroptosis in the innate
immune response. Although thismay be a protectivemechanism
for isolated progenitor cells, we show that systemic activation of
Caspase-1 in the progenitor cell compartment compromises
hematopoiesis. This suggests that inhibition of the NLRP1
inflammasome may alleviate the profound anemia, leukopenia,
and immunosuppression commonly found in septic patients
and those undergoing chemotherapy.
EXPERIMENTAL PROCEDURES
Mice
The Casp1/, Asc/, Il18/, Ifng/, Cd3/, uMT/, Il1a/, and Il1r/
mouse strains were generated on or had been backcrossed at least ten
generations with the C57BL/6 background. ENU mutagenesis was performed
as described previously. All animal experiments complied with the regulatory
standards of, and were approved by, the Walter and Eliza Hall Institute Animal
Ethics Committee.
NLRP1 Targeting
MICER plasmids (MHPP282m18 and MHPN379 g03) containing DNA
surrounding the NLRP1 locus were used for homologous recombination into
the mouse genome and subsequent deletion of loxP-flanked DNA. Each
construct was sequentially electroporated into mouse ES cells, followed by
a further electroporation of a plasmid expressing Cre recombinase that deletes
the entirety of Nlrp1c and Nlrp1b and exons 1–10 of Nlrp1a. BamHI probes
were used to confirm correct M18 insertion and Cre-mediated recombination
in ES cells by Southern blot analysis.
Hematology and Flow Cytometry
Automated cell countswere performed on blood collected from the retroorbital
plexus into Microtainer tubes containing EDTA (Sarstedt), via an Advia
2120 hematological analyzer (Siemens, Munich, Germany). Flow cytometric
analysis of hematopoietic cells was performed with a BD Biosciences
LSRFortessa cell analyzer.unity 37, 1009–1023, December 14, 2012 ª2012 Elsevier Inc. 1021
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Organs were collected in 10% buffered formalin. Tissue sections were
prepared from paraffin blocks and stained with hematoxylin and eosin or
Masson’s Trichrome Stain.
Bone Marrow Chimeras
For hematopoietic reconstitution experiments, congenic Ly5.1-expressing
BALB/c.SJL mice or Ly5.2-expressing Nlrp1aQ593P/Q593P BALB/c.SJL
mice were reconstituted with 5 3 106 Ly5.2-expressing wild-type or
Nlrp1aQ593P/Q593P BALB/c.SJL bone marrow cells. For some experiments,
Ly5.1-expressing C57BL/6J mice were reconstituted with a mix of 2.5 3 106
Ly5.2-expressing C57BL/6J Nlrp1/ bone marrow cells and 2.5 3 106 bone
marrow cells from C57BL/6J ubiquitin-GFP mice (Schaefer et al., 2001).
Recipient mice received two 5.5 Gy doses of irradiation given 3 hr apart.
Isolation of Bone Marrow-Derived Macrophages and Dendritic Cells
Macrophages were derived from 107 bone marrow cells in L929 cell condi-
tioned medium for 5 days at 37C/10% CO2. Dendritic cells were derived in
media containing 20 ng/ml GM-CSF for 10 days.
Cytokine ELISA
Cytokines were measured by ELISA (eBioscience, CA, USA) or BioPlex
(BioRad, CA, USA) according to the manufacturer’s instructions. IL-18 was
analyzed by sandwich ELISA with IL-18-specific antibodies (R&D Systems,
MN, USA).
Progenitor Cell Analysis
Clonal cultures of hematopoietic cells were performed as described (Croker
et al., 2004). For recloning assays, single colonies were removed at day 7
from cultures of bone marrow stimulated by 100 ng/ml SCF + 100 ng/ml IL-6
and resuspended in agar, then added to plates containing 10 ng/ml GM-
CSF, 10 ng/ml M-CSF, or 100 ng/ml SCF + 10 ng/ml murine IL-3 + 4 U/ml
Epo for a further 7 days. Cultures were then fixed and stained for acetylcholin-
esterase, Luxol Fast Blue, and hematoxylin, and the cellular composition of
each colony determined at 1003 to 4003 magnification. For analysis of
progenitor cell viability, 1.53 104 linc-kit+ bone marrow cells were monitored
for viability as described (Croker et al., 2011). For RNA expression analysis,
Nlrp1a, Nlrp3, Asc, and Actin was quantified by reverse-transcriptase PCR
from 3.75–7.5 ng cDNA prepared from HSC (linc-kithiSca-1hiIL-7R), CMP
(linSca-1c-kit+CD34+CD16/32lo), GMP (linSca-1c-kit+CD34+CD16/32hi),
and CLP (linSca-1+c-kit+IL-7R+). Caspase-1 activity was measured by flow
cytometry after labeling linc-kit+ cells with a fluorescent inhibitor probe
FAM-YVAD-FMK for Caspase-1 (ImmunoChemistry Technologies, Blooming-
ton, MN, USA).
Immunoblotting
Cell lysates and supernatants were analyzed by immunoblot according to
protocols described previously (Croker et al., 2004).
Lymphocytic Choriomeningitis Virus Infection
Mice were infected by intravenous injection of 2 3 106 PFU LCMV docile or
3.6 3 105 PFU LCMV clone 13. Virus titers were determined with protocols
described previously (Battegay et al., 1991). Staining of LCMV-specific
T cells with tetramers was performed according to protocols described previ-
ously (Pellegrini et al., 2009). For intracellular detection of LCMVnucleoprotein,
purified linc-kit+ bone marrow progenitor cells were cultured in 100 ng/ml
SCF + 10 ng/ml murine IL-3 + 4 U/ml Epo for 3 days, then cells were fixed in
BD Biosciences Fixation and Permeabilisation Solution and permeabilized
in BD Biosciences Perm/Wash buffer according to the manufacturer’s
instructions, before staining with an antibody specific to LCMV nucleoprotein
(clone VL4).
Statistics
Unless otherwise specified, data are presented as mean ± standard deviation
(SD) or standard error of the mean (SEM). Comparisons were performed with
a Student’s t test, Fisher’s exact test, or ANOVA followed by a Student
Newman Keuls test. Survival curves were analyzed with a log-rank (Mantel-
Cox) test.1022 Immunity 37, 1009–1023, December 14, 2012 ª2012 Elsevier InSUPPLEMENTAL INFORMATION
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